# A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

> **NCT01489826** · PHASE1 · COMPLETED · sponsor: **e-Therapeutics PLC** · enrollment: 40 (actual)

## Conditions studied

- Solid Tumour

## Interventions

- **DRUG:** Dexanabinol
- **OTHER:** Cremophor

## Key facts

- **NCT ID:** NCT01489826
- **Lead sponsor:** e-Therapeutics PLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489826, "A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01489826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*